AG
Distinguished in Acrorenal Mandibular Syndrome
Check Dr. Abhimanyu Garg's experience treating your condition:
About Dr. Abhimanyu Garg

Abhimanyu Garg is an Endocrinologist in Dallas, Texas. Garg has been practicing medicine for over 42 years and is rated as a Distinguished expert by MediFind in the treatment of Acrorenal Mandibular Syndrome. He is also highly rated in 14 other conditions, according to our data. His top areas of expertise are Congenital Generalized Lipodystrophy, Familial Partial Lipodystrophy, Gigantism, Familial Hypertriglyceridemia, and Gastric Bypass. He is licensed to treat patients in Texas. Garg is currently accepting new patients.

His clinical research consists of co-authoring 104 peer reviewed articles and participating in 13 clinical trials in the past 15 years. In particular, he has co-authored 8 articles in the study of Acrorenal Mandibular Syndrome.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Abhimanyu Garg it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
2001 Inwood Rd, Dallas, TX 75390
Other Locations
5303 Harry Hines Blvd, Dallas, TX 75390
Background & Education
Graduate Institution
Other, 1981
Specialties
Endocrinology
Licenses
Internal Medicine in TX
Hospital Affiliations
Parkland Health And Hospital System
Dallas VA Medical Center
William P Clements Jr University Hospital
Languages Spoken
English
Hindi
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A 36-Month, Multicenter, Open Label Phase 4 Study to Evaluate the Immunogenicity of Daily SC Metreleptin Treatment in Patients With Generalized Lipodystrophy
MEASuRE: Metreleptin Effectiveness And Safety Registry
Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients
Novel Therapies for Metabolic Complications in Patients With Lipodystrophies
Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy
The Study of Mechanisms of Lipodystrophy in HIV-Infected Patients
Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients
Open Label Single Center Pilot Study to Study Teh Effects of Metreleptin Administration in Patients With Type 1 Diabetes Mellitus ( T1DM ).
Mecahnisms of Lipodystrophy in HIV-Infected Patients
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia
Therapeutic Approaches to HAART-Induced Lipodystrophy
View 11 Less Clinical Trials -

105 Total Publications

Autosomal recessive progeroid syndrome due to homozygosity for a TOMM7 variant.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Distinguished
Advanced